Figure S1. (A): Sirt6 mRNA level after RA induced JM8A3 ES cells differentiation. All gene mRNA levels were measured by real time PCR; Oct4, Sox2 were represented as positive control, GAPDH was used as reference gene. All data were shown as mean values ± SD from three independent experiments. (*, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001). (B): Two CRISPR sgRNAs were designed to knockout region between exon4 and exon5 (highlighted in yellow) (781 bp); PCR primers and fragment used for genotyping was shown on the top. (C): Genotyping of the Sirt6 knockout JM8 ES clones by PCR; One pure knockout clone (D12) was selected. (D): Western blot to validate the expression of Sirt6 in Sirt6 knockout JM8 ES cells. (JPG 542 kb
CRISPR/Cas9 induced DSBs at the Rosa26 intronic XbaI site in mouse zygotes; Figure S2: Sequence anal...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
Figure S2. CRISPR-Cas9 targeting strategy and editing efficiency. (a) Schematic of exon 1 of human P...
Figure S2. (A): Sirt6/OG2 MEF genotype. Two sets of primers were used to genotype Sirt6 and Oct4-GFP...
Table S1. Differential expression genes in Sirt6-null iPS-like cells relative to wild-type controls....
Figure S4. (A): Three stages of in vitro hematopoietic differentiation from mES cells and iPS cells....
Figure S3. (A): iPSC clones derived from wild-type and Sirt6-null Oct4-GFP MEF cells. IPS clones wer...
Table S3. Differential expression genes in Sirt6-null MEFs relative to wild-type controls. (XLSX 97 ...
Table S2. Gene ontology analysis from downregulated gene sets in Sirt6-null iPS-like cells. (XLSX 41...
Table S4. Gene ontology analysis from downregulated gene sets in Sirt6-null MEFs. (XLSX 10 kb
Figure S1. Cloning strategy to make donor plasmids. Figure S2. CRISPR-SONIC enables IRES-GFP integra...
Additional file 4: Supplementary Fig. 4. Effects of SIRT1 loss on Notch-induced leukemia. a Schemati...
Figure S2. Pax7EGFP copy number variation analysis and in-depth genotyping, and effect of transgene ...
(A) Flow cytometry was used to detect surface marker changes in siRNA experiments during DC (-si STA...
Validation of the murine Sall2 gene deletion by CRISPR-Cas9. A) Representative Western blot for SALL...
CRISPR/Cas9 induced DSBs at the Rosa26 intronic XbaI site in mouse zygotes; Figure S2: Sequence anal...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
Figure S2. CRISPR-Cas9 targeting strategy and editing efficiency. (a) Schematic of exon 1 of human P...
Figure S2. (A): Sirt6/OG2 MEF genotype. Two sets of primers were used to genotype Sirt6 and Oct4-GFP...
Table S1. Differential expression genes in Sirt6-null iPS-like cells relative to wild-type controls....
Figure S4. (A): Three stages of in vitro hematopoietic differentiation from mES cells and iPS cells....
Figure S3. (A): iPSC clones derived from wild-type and Sirt6-null Oct4-GFP MEF cells. IPS clones wer...
Table S3. Differential expression genes in Sirt6-null MEFs relative to wild-type controls. (XLSX 97 ...
Table S2. Gene ontology analysis from downregulated gene sets in Sirt6-null iPS-like cells. (XLSX 41...
Table S4. Gene ontology analysis from downregulated gene sets in Sirt6-null MEFs. (XLSX 10 kb
Figure S1. Cloning strategy to make donor plasmids. Figure S2. CRISPR-SONIC enables IRES-GFP integra...
Additional file 4: Supplementary Fig. 4. Effects of SIRT1 loss on Notch-induced leukemia. a Schemati...
Figure S2. Pax7EGFP copy number variation analysis and in-depth genotyping, and effect of transgene ...
(A) Flow cytometry was used to detect surface marker changes in siRNA experiments during DC (-si STA...
Validation of the murine Sall2 gene deletion by CRISPR-Cas9. A) Representative Western blot for SALL...
CRISPR/Cas9 induced DSBs at the Rosa26 intronic XbaI site in mouse zygotes; Figure S2: Sequence anal...
Figure S1. Reduced expression of Zc3h8 in a second cell line and using a second targeting shRNA lead...
Figure S2. CRISPR-Cas9 targeting strategy and editing efficiency. (a) Schematic of exon 1 of human P...